Trident Sign Associated with Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy
Margaret Upchurch1, Matthew Doerfler2, Andrew Wolf1
1Neuroimmunology, University of Colorado, 2Neuroimmunology, Childrens Hospital Colorado
Objective:
To report a case of a 67-year-old woman who presented with lower extremity sensorimotor deficits and was found to have a longitudinally extensive transverse myelitis with central and dorsal-subpial enhancement in a “trident sign” pattern due to GFAP astrocytopathy.
Background:

The trident sign is a radiological finding on MRI classically described in neurosarcoidosis. The trident sign describes the appearance of central canal enhancement in addition to dorsal subpial enhancement on axial MRI of the spinal cord, giving the appearance of a trident or three-pronged spear. The trident sign has frequently been described with spinal cord involvement of neurosarcoidosis, but it has also been reported with other inflammatory causes of longitudinally extensive transverse myelitis including HTLV-1 infection and neuromyelitis optica spectrum disorder, as well as with diffuse large B-cell lymphoma.

Design/Methods:
Case report
Results:

A 67-year-old woman presented with 4 weeks of progressive, bilateral leg numbness and weakness. Brain MRI demonstrated speckled enhancement in the pons and middle cerebellar peduncles. Spine MRI demonstrated longitudinally extensive T2 hyperintensity with central and dorsal-subpial enhancement in a trident sign appearance. CSF showed 5 nucleated cells/uL (88% lymphocytes, 12% monocytes), 28 red blood cells/uL, glucose 63 mg/dL, and protein 130 mg/dL. CSF GFAP antibodies were positive at 1:32 on an otherwise negative myelopathy panel (Mayo) supporting diagnosis of GFAP astrocytopathy. Serum myelopathy panel (Mayo) and CSF cytokine panel (ARUP), flow cytometry, and cytology were unremarkable, as was whole-body FDG PET. She improved clinically with resolution of MRI abnormalities after intravenous methylprednisolone and plasma exchange. She has been stable for 12 months on maintenance rituximab.   

Conclusions:

This case demonstrates that the trident sign is not specific to neurosarcoidosis and may be seen in other neuroinflammatory conditions. This case suggests a role for autoantibody testing in the evaluation of a patient with longitudinally extensive transverse myelitis with a trident sign pattern.

10.1212/WNL.0000000000215139
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.